These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11410512)

  • 41. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
    Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H
    Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.
    Hsu HS; Wen CK; Tang YA; Lin RK; Li WY; Hsu WH; Wang YC
    Clin Cancer Res; 2005 Aug; 11(15):5410-6. PubMed ID: 16061855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter hypermethylation of resected bronchial margins: a field defect of changes?
    Guo M; House MG; Hooker C; Han Y; Heath E; Gabrielson E; Yang SC; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Aug; 10(15):5131-6. PubMed ID: 15297416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study on structure change and hypermethylation of p16 gene in multiple myeloma].
    Fu W; Hou J; Wang D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):573-6. PubMed ID: 11855144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity.
    Raveh T; Berissi H; Eisenstein M; Spivak T; Kimchi A
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1572-7. PubMed ID: 10677501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
    Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
    Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
    Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
    Tang X; Khuri FR; Lee JJ; Kemp BL; Liu D; Hong WK; Mao L
    J Natl Cancer Inst; 2000 Sep; 92(18):1511-6. PubMed ID: 10995806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypermethylation of the RASSF1A gene in gliomas.
    Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y
    Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
    Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
    Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
    Chim CS; Liang R; Leung MH; Kwong YL
    J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DAP kinase links the control of apoptosis to metastasis.
    Inbal B; Cohen O; Polak-Charcon S; Kopolovic J; Vadai E; Eisenbach L; Kimchi A
    Nature; 1997 Nov; 390(6656):180-4. PubMed ID: 9367156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
    Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
    Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
    Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
    Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.